Two-sided culture of human placental trophoblast. Morphology, immunocytochemistry and permeability properties.
We describe the culture of human term placental trophoblast cells on cell-free amniotic membrane, with medium on both sides. Over the course of 2 days, the isolated cells, initially simple, mononucleated and probably cytotrophoblast, form a confluent layer of multinucleated syncytial cells with morphological and immunocytochemical properties of syncytiotrophoblast. This layer becomes polarized with respect to morphology, alkaline phosphatase distribution and hCG secretion. Contamination with amnion cells, and with other cell types that are present in placental tissue, was less than 1 per cent. A preliminary investigation of the permeability properties of the preparation showed that the trophoblast cell layer, rather than the amniotic membrane, was rate-limiting to transtrophoblast transfer, but that possible effects of the supporting membrane should be considered. The transtrophoblast transfer of D-glucose and the non-metabolisable analogue, 3-O-methyl-D-glucose (3OMG), had saturable and non-saturable/leak components in both directions, indicating that carrier-mediated processes were involved. The non-metabolisable amino acid 2-aminoisobutyrate (AIB) was both accumulated within the trophoblast cells, and transferred by saturable and non-saturable processes from the microvillous side, but no saturable accumulation or transfer was observed from the basal side, at the concentrations tried. The results suggest that this model may prove suitable for studies of transtrophoblast transfer.
Bullen
B E
BE
Royal Postgraduate Medical School, Institute of Obstetrics and Gynaecology, Queen Charlotte's and Chelsea Hospital, London, UK.
Bloxam
D L
DL
Ryder
T A
TA
Mobberley
M A
MA
Bax
C M
CM
D019325:3-O-Methylglucose; D000418:Albumins / Q000493:pharmacokinetics; D000469:Alkaline Phosphatase / Q000493:pharmacokinetics; D000621:Aminoisobutyric Acids / Q000493:pharmacokinetics; D002463:Cell Membrane Permeability; D006063:Chorionic Gonadotropin / Q000493:pharmacokinetics; D046508:Culture Techniques / Q000379:methods; D005947:Glucose / Q000493:pharmacokinetics; D006801:Humans; D007150:Immunohistochemistry; D007444:Inulin / Q000493:pharmacokinetics; D007633:Keratins / Q000493:pharmacokinetics; D008757:Methylglucosides / Q000493:pharmacokinetics; D008854:Microscopy, Electron; D013395:Sucrose / Q000493:pharmacokinetics; D014327:Trophoblasts / Q000378:metabolism*; D014746:Vimentin / Q000493:pharmacokinetics
D000418:Albumins; D000621:Aminoisobutyric Acids; D006063:Chorionic Gonadotropin; D008757:Methylglucosides; D014746:Vimentin; D019325:3-O-Methylglucose; C100049:2-aminoisobutyric acid; D013395:Sucrose; D007633:Keratins; D007444:Inulin; D000469:Alkaline Phosphatase; D005947:Glucose